Cargando…
Symptomatic Care in Multiple System Atrophy: State of the Art
Without any disease-modifying treatment strategy for multiple system atrophy (MSA), the therapeutic management of MSA patients focuses on a multidisciplinary strategy of symptom control. In the present review, we will focus on state of the art treatment in MSA and additionally give a short overview...
Autores principales: | Grossauer, Anna, Sidoroff, Victoria, Heim, Beatrice, Seppi, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125958/ https://www.ncbi.nlm.nih.gov/pubmed/35581488 http://dx.doi.org/10.1007/s12311-022-01411-6 |
Ejemplares similares
-
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
por: Sidoroff, Victoria, et al.
Publicado: (2022) -
α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis
por: Grossauer, Anna, et al.
Publicado: (2023) -
Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?
por: Leys, Fabian, et al.
Publicado: (2022) -
A Review on the Clinical Diagnosis of Multiple System Atrophy
por: Stankovic, Iva, et al.
Publicado: (2022) -
Characterization of gait variability in multiple system atrophy and Parkinson’s disease
por: Sidoroff, Victoria, et al.
Publicado: (2020)